跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sotalol (iv
首页
药物
Sotalol (iv
Sotalol (iv
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method of administering sotalol IV/switch
US 10799138 B2
申请人: UNIV MARYLAND
优先权: 2019
US
7 件公开
Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US 11344518 B2
申请人: ALTATHERA PHARMACEUTICALS LLC
优先权: 2020
US
METHODS OF ADMINISTERING SOTALOL HYDROCHLORIDE
US 2023225997 A1
申请人: ALTATHERA PHARMACEUTICALS LLC
优先权: 2023
US
METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL HYDROCHLORIDE
US 2023248674 A1
申请人: ALTATHERA PHARMACEUTICALS LLC
优先权: 2023
US
METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL
US 20240261242 A1
申请人: ALTATHERA PHARMACEUTICALS LLC
优先权: 2024
US
METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL HYDROCHLORIDE FOR THE TREATMENT OF PEDIATRIC PATIENTS
US 20250213504 A1
申请人: ALTATHERA PHARMACEUTICALS LLC
优先权: 2025
US
药物
反馈